leadf
logo-loader
viewArix Bioscience PLC

Arix Bioscience says portfolio company LogicBio Therapeutics announces pricing for public offering

The firm will issue 7mln shares of common stock at US$6 each for total gross proceeds of approximately US$42mln

Arix Bioscience PLC - Arix Bioscience says portfolio company LogicBio Therapeutics announces pricing for public offering

Arix Bioscience PLC (LON:ARIX) said that its portfolio company LogicBio Therapeutics, Inc. (NASDAQ: LOGC), has announced the pricing of its underwritten public offering in the US.

Venture capital company Arix said it has agreed to invest $3mln in the offering and retains a stake of 9.4% in LogicBio.

LogicBio will issue 7mln shares of common stock at US$6 each for total gross proceeds of approximately US$42mln, before deducting underwriting discounts and commissions and offering expenses.

READ: Arix Biosciences notes new data from Autolus on lymphona treatment

In addition, LogicBio has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock, at the public offering price less underwriting discounts and commissions.

The offering is expected to close on October 5.

 

Quick facts: Arix Bioscience PLC

Price: 108 GBX

LSE:ARIX
Market: LSE
Market Cap: £146.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arix Bioscience PLC named herein, including the promotion by the Company of Arix Bioscience PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE flounders as imminent Brexit talks loom

The FTSE is mixed this Tuesday despite the weaker pound. Sterling is still battling no deal Brexit fears as the UK Prime Minister Boris Johnson threatens that if no progress on the talks with the EU is made week, preparations for a no deal will be ramped up. Britain’s biggest sports retailer...

on 8/9/20

2 min read